Arrhythmogenic right ventricular dysplasia

American Family Physician

Volumn 73, Issue 8, 2006, Pages

  Anderson, Eric L ^a,b  

^a Naval Air Station Jacksonville   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE ACETATE; LIDOCAINE; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL DERIVATIVE; SOTALOL;

ADIPOSE TISSUE; ANGIOCARDIOGRAPHY; ARTICLE; ATHLETE; CAUSE OF DEATH; CLINICAL FEATURE; DEFIBRILLATOR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILY HISTORY; FUNCTIONAL ASSESSMENT; GROUPS BY AGE; HEART DEPOLARIZATION; HEART GRAFT; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART RATE; HEART REPOLARIZATION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE DYSPLASIA; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE SEPTUM; HUMAN; LIFESTYLE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RADIOFREQUENCY ABLATION; SUDDEN DEATH; TACHYCARDIA; THORAX PAIN; TISSUE CHARACTERIZATION; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION;

ALGORITHMS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 33645976781     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Fontaine GH, Guiraudon G, Frank R, Vedel J, Grosgogeat Y, Calrol C, et al. Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanisms and selection for surgery. In: Kulbertus HE, ed. Re-entrant arrhythmias: mechanisms and treatment. Baltimore: University Park Press, 1977:334-50.
2. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982;65:384-98.
3. Ahmad F. The molecular genetics of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Clin Invest Med 2003;26:167-78.
4. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
5. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 1990;89:588-96.
6. Hosey RG, Armsey TD. Sudden cardiac death. Clin Sports Med 2003;22:51-66.
7. Peters S, Peters H, Thierfelder L. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy. Int J Cardiol 1999;71:243-50.
8. Nava A, Rossi L, Thiene G, eds. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Amsterdam: Elsevier, 1997.
9. Kayser HW, van der Wall EE, Sivananthan MU, Plein S, Bloomer TN, de Roos A. Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics 2002; 22:639-50.
10. Ananthasubramaniam K, Khaja F. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: review for the clinician. Prog Cardiovasc Dis 1998;41:237-46.
11. Fontaine G, Fontaliran F, Hébert JL, Chemla D, Zenati O, Lecarpentier Y, et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Med 1999;50:17-35.
12. Saliba WI, Natale A. Ventricular tachycardia syndromes. Med Clin North Am 2001;85:267-304.
13. Wlodarska EK, Konka M, Kepski R, Zaleska T, Ploski R, Ruzyllo W, et al. Familial form of arrhythmogenic right ventricular cardiomyopathy. Kardiol Pol 2004;60:1-14.
14. Marcus F, Towbin JA, Zareba W, Moss A, Calkins H, Brown M, et al. Arrhythmogenic right ventricular dysplasia/ cardiomyopathy (ARVD/C): a multidisciplinary study design and protocol. Circulation 2003;107:2975-8.
15. Rossi PA. Arrhythmogenic right ventricular dysplasia - clinical features. Eur Heart J 1989;10(suppl D):7-9.
16. Coumbe A, Perez-Martinez AL, Fegan AW, Hill IR. Arrhythmogenic right ventricular dysplasia (ARVD): an overlooked and underdiagnosed condition? Med Sci Law 1997;37:262-5.
17. O'Donnell D, Cox D, Bourke J, Mitchell L, Furniss S. Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J 2003;24:801-10.
18. Lascault G, Laplaud O, Frank R, Tonet J, Fontaine G, Grosgogeat Y, et al. Ventricular tachycardia features in right ventricular dysplasia. Circulation 1988;78:300.
19. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994;71:215-8.
20. Bomma C, Rutberg J, Tandri H, Nasir K, Roguin A, Tichnell C, et al. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 2004;15:300-6.
21. Hamid MS, Norman M, Quraishi A, Firoozi S, Thaman R, Gimeno JR, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/ dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-50.
22. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841-2.
23. Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. Circulation 1998;97:1532-5.
24. Stevenson I, Kalman J. Magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular cardiomyopathy: the gold standard or just another imaging modality? J Interv Card Electrophysiol 2004;10:27-9.
25. Lopez-Fernandez T, Garcia-Fernandez MA, Perez David E, Moreno Yanguela M. Usefulness of contrast echocardiography in arrhythmogenic right ventricular dysplasia. J Am Soc Echocardiogr 2004;17:391-3.
26. White JB, Razmi R, Nath H, Kay GN, Plumb VJ, Epstein AE. Relative utility of magnetic resonance imaging and right ventricular angiography to diagnose arrhythmogenic right ventricular cardiomyopathy. J Interv Card Electrophysiol 2004;10:19-26.
27. Blake LM, Scheinman MM, Higgins CB. MR features of arrhythmogenic right ventricular dysplasia. AJR Am J Roentgenol 1994;162:809-12.
28. Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F, et al. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 1992;70:1589-95.
29. Tandri H, Bomma C, Calkins H, Bluemke DA. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging 2004;19:848-58.
30. Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters PE. Arrhythmogenic right ventricular disease: MR imaging vs angiography. AJR Am J Roentgenol 1993; 161:549-55.
31. Iesaka Y, Hiroe M, Aonuma K, Nitta J, Nogami A, Tokunaga T, et al. Usefulness of electrophysiologic study and endomyocardial biopsy in differentiating arrhythmogenic right ventricular dysplasia from idiopathic right ventricular tachycardia. Heart Vessels 1990; 5(suppl):65-9.
32. Niroomand F, Carbucicchio C, Tondo C, Riva S, Fassini G, Apostolo A, et al. Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia. Heart 2002;87:41-7.
33. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992;86:29-37.
34. Leclercq JF, Coumel P. Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia. Eur Heart J 1989;10(suppl D):61-7.
35. Fontaine G, Gallais Y, Fornes P, Hebert JL, Frank R. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Anesthesiology 2001;95:250-4.
36. Fontaine G, Prost-Squarcioni C. Implantable cardioverter defibrillator in arrhythmogenic right ventricular cardiomyopathies. Circulation 2004;109:1445-7.
37. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2002;40:1703-19.
38. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy. J Am Coll Cardiol 2004;43:1843-52.
39. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108:3084-91.
40. Gear K, Marcus F. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2003;107:e31-3.
41. Harrison TC, Kessler D. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Lung 2001;30:360-9.